cheqfx
promo_leaderboard Ad
‹ All stocks
HLN

Haleon plc

HLN · NYSE · Healthcare
$9.26
▲ $0.24 (2.66%)
$8.72 $8.90 $9.08 $9.26 $9.26 Oct 03 Oct 07 Oct 10
Day range
$9.08 – $9.26
Year range
$8.65 – $11.28
Open
$9.10
Previous close
$9.02
Market cap
$40.78B
Volume (24h)
$20.3M
Volume (52w)
$187.83M
Performance
7D
▲ 5.23%
1M
▲ 0.33%
3M
▼ -6.09%
6M
▼ -5.80%
1Y
▲ 2.66%
YTD
▼ -7.40%
3Y
▲ 9.46%
5Y
▲ 26.85%
All-time
▲ 26.85%
Key statistics
P/E ratio
12.24
EPS (TTM)
$0.76
Dividend yield
2.14%
Dividend (TTM)
$0.20
Payout ratio
26.19%
Shares outstanding
4.4B
About Haleon plc

Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.

Visit website
Country: United States of America
More in Healthcare
promo infeed Ad